Prognostic value, immune signature and molecular mechanisms of the SUMO family in pancreatic adenocarcinoma

Background: Pancreatic adenocarcinoma (PAAD) has a high degree of malignancy and a very poor prognosis, and the 5-year overall survival rate of patients is approximately 7%. To improve the prognosis of patients with PAAD, a more comprehensive and in-depth study of the pathogenesis of PAAD and the id...

Descripción completa

Detalles Bibliográficos
Autores principales: Duan, Yunjie, Du, Yongxing, Mu, Yongrun, Gu, Zongting, Wang, Chengfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798011/
https://www.ncbi.nlm.nih.gov/pubmed/36589239
http://dx.doi.org/10.3389/fmolb.2022.1096679

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798011/
https://www.ncbi.nlm.nih.gov/pubmed/36589239
http://dx.doi.org/10.3389/fmolb.2022.1096679

Ejemplares similares